NWMP
BIIB icon

Noble Wealth Management PBC’s Biogen BIIB Stock Holding History

Noble Wealth Management PBC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$958 Hold
7
– – ﹤0.01% 489
2024
Q4 		$1.07K Buy
+7
New +$1.18K ﹤0.01% 448

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Noble Wealth Management PBC's BIIB Position: Q1 2025 in Review

Noble Wealth Management PBC held its Biogen (BIIB) position steady in Q1 2025 at 7 shares worth $958. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Noble Wealth Management PBC first reported a position in BIIB in Q4 2024 and has held it in 2 quarters since. The position peaked at $1.07K in Q4 2024. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Noble Wealth Management PBC held 7 shares of Biogen worth $958 as of Q1 2025.
  • Noble Wealth Management PBC left its Biogen share count unchanged in Q1 2025.
  • Biogen made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q1 2025, its #489 holding.
  • Noble Wealth Management PBC first reported a position in Biogen in Q4 2024 and has held it in 2 quarters since.
  • Noble Wealth Management PBC's Biogen position peaked at $1.07K in Q4 2024.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Noble Wealth Management PBC's 13F filing for Q1 2025, filed 15 Apr 2025.